Northrup et al., 1972 - Google Patents
Adjuvant effect of cholera enterotoxin on the immune response of the mouse to sheep red blood cellsNorthrup et al., 1972
- Document ID
- 8482062971888594778
- Author
- Northrup R
- Fauci A
- Publication year
- Publication venue
- Journal of Infectious Diseases
External Links
Snippet
Adjuvant Effect of Cholera Enterotoxin on the Immune Response of the Mouse to Sheep
Red Blood Cells Page 1 THE JOURNAL OF INFECTIOUS DISEASES • VOL. 125, NO.6·
JUNE 1972 © 1972 by the University of Chicago. All rights reserved. Adjuvant Effect of …
- 101700032127 ETX1 0 title abstract description 25
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Northrup et al. | Adjuvant effect of cholera enterotoxin on the immune response of the mouse to sheep red blood cells | |
| Holmgren et al. | Mechanisms of disease and immunity in cholera: a review | |
| DE69527202T3 (en) | PROTEIN ADJUVANTIES | |
| JP3485184B2 (en) | Interleukin-containing stable vaccine composition | |
| Cox et al. | Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine | |
| Djordjevic et al. | Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant | |
| Rivera et al. | Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants | |
| Tamura et al. | Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine | |
| WO1998056415A1 (en) | Purified saponins as oral adjuvants | |
| Ben Ahmeida et al. | The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus | |
| Meyer et al. | Plague immunization. IV. Clinical reactions and serologic response to inoculations of Haffkine and freeze-dried plague vaccine | |
| KR100202052B1 (en) | Detoxification method of bordetella pertussis toxin and the b. pertussis toxin detoxified by this method | |
| Hilleman | A forward look at viral vaccines: with special reference to a new immunologic adjuvant | |
| Lucas et al. | Antibody production and protection against influenza virus in immunodeficient mice | |
| EP1123711B1 (en) | Attenuated toxins as adjuvants | |
| Yamaguchi et al. | Antibody formation against Salmonella flagella by an immune ribonucleic acid fraction | |
| Athanassiades | Adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in mice: enhancement of cell-mediated immunity by subcutaneous administration of adjuvant and antigen | |
| Nagy et al. | Iscom (Immunostimulating Complex) Vaccines Containing Mono‐or Polyvalent Pili of Enterotoxigenic E. coli; Immune Response of Rabbit and Swine | |
| CN110507819B (en) | Application of artesunate as immunologic adjuvant in preparation of rabies vaccine | |
| Norrby et al. | Humoral immunity to canine distemper after immunization of dogs with inactivated and live measles virus | |
| Ananthanarayan | The fabric of virus elementary bodies | |
| AT410172B (en) | METHOD FOR PRODUCING VACCINE FORMULATION | |
| Morter et al. | Evaluating the efficacy of a Haemophilus somnus bacterin in a controlled field trial | |
| Relyveld et al. | Preparation of highly immunogenic protein conjugates by direct coupling to glutaraldehyde-treated cells: Comparison with commonly used preparations | |
| Stone et al. | Tick‐paralysis toxoid: an effective immunizing agent against the toxin of Ixodes holocyclus |